Eisai Co Ltd (ESAIY)
10.53
-0.07
(-0.66%)
USD |
OTCM |
May 21, 15:58
Eisai Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 2.308B |
| May 17, 2024 | 2.366B |
| May 16, 2024 | 2.400B |
| May 15, 2024 | 2.466B |
| May 14, 2024 | 2.421B |
| May 13, 2024 | 2.360B |
| May 10, 2024 | 2.376B |
| May 09, 2024 | 2.360B |
| May 08, 2024 | 2.311B |
| May 07, 2024 | 2.312B |
| May 06, 2024 | 2.337B |
| May 03, 2024 | 2.319B |
| May 02, 2024 | 2.292B |
| May 01, 2024 | 2.237B |
| April 30, 2024 | 2.202B |
| April 29, 2024 | 2.196B |
| April 26, 2024 | 2.122B |
| April 25, 2024 | 2.139B |
| April 24, 2024 | 2.179B |
| April 23, 2024 | 2.093B |
| April 22, 2024 | 2.085B |
| April 19, 2024 | 2.013B |
| April 18, 2024 | 1.944B |
| April 17, 2024 | 2.007B |
| April 16, 2024 | 2.062B |
| Date | Value |
|---|---|
| April 15, 2024 | 2.036B |
| April 12, 2024 | 2.056B |
| April 11, 2024 | 2.059B |
| April 10, 2024 | 2.054B |
| April 09, 2024 | 2.141B |
| April 08, 2024 | 2.188B |
| April 05, 2024 | 2.151B |
| April 04, 2024 | 2.113B |
| April 03, 2024 | 2.076B |
| April 02, 2024 | 2.116B |
| April 01, 2024 | 2.138B |
| March 28, 2024 | 2.222B |
| March 27, 2024 | 2.265B |
| March 26, 2024 | 2.288B |
| March 25, 2024 | 2.235B |
| March 22, 2024 | 2.277B |
| March 21, 2024 | 2.351B |
| March 20, 2024 | 2.288B |
| March 19, 2024 | 2.280B |
| March 18, 2024 | 2.345B |
| March 15, 2024 | 2.291B |
| March 14, 2024 | 2.252B |
| March 13, 2024 | 2.400B |
| March 12, 2024 | 2.414B |
| March 11, 2024 | 2.345B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.944B
Minimum
Apr 18 2024
32.04B
Maximum
Jun 07 2021
14.12B
Average
15.58B
Median
Enterprise Value Benchmarks
| Biogen Inc | 39.18B |
| Takeda Pharmaceutical Co Ltd | 70.56B |
| Nxera Pharma Co Ltd | 1.009B |
| PeptiDream Inc | 1.517B |
| Healios KK | 62.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 61.31M |
| Revenue (Quarterly) | 1.330B |
| Total Expenses (Quarterly) | 1.270B |
| EPS Diluted (Quarterly) | 0.2138 |